Sathasivam, Hans Prakash
Davan, Sangeetha Passu
Chua, Szu May
Rohaizat, Rahmuna Fazlina
Japar, Rohaizam
Zakaria, Zahirrudin
Ahmad, Abd Razak
Hashim, Hasmah
Marimuthu, Shashi Gopalan
Liew, Yew Toong
Yong, Doh Jeing
Vairavan, Pappathy
Mohan Singh, Avatar Singh
Goh, Benjamin Hong Beng
Yusof, Zulkifli
Abu Dahari, Khairul Azlan Shahril
Haron, Ali
Mansor, Masaany
Ibrahim, Mohd Zambri
Muhammad Abdul Kadar, Shiraz Qamil
Hamal, Mohamad Hazri
Wan Mohamad, Wan Emelda
,
Funding for this research was provided by:
Ministry of Health Research Grant (NMRR-20-49-52574)
Article History
Received: 12 September 2023
Accepted: 9 November 2023
First Online: 28 November 2023
Declarations
:
: This study has ethical approval from the Malaysian Medical Research and Ethics Committee (NMRR-20-49-52574) and complies with local legislation and guidelines. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: HPS has been funded by a pharmaceutical company for a separate investigator-initiated study pertaining to human papillomavirus. Aside from that, the authors declare that they have no competing interests.